CRISPR 技术的全球市场 - 市场规模、份额、成长分析：按最终用户、按应用划分 - 行业预测 (2023-2030)

Global CRISPR Technology Market Size, Share, Growth Analysis, By End-User(Pharmaceutical and biotechnology companies and academic and research institutes), By Application(Drug discovery and development and agriculture) - Industry Forecast 2023-2030

出版日期: 2023年10月20日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年全球CRISPR技术市场规模为25.4亿美元，2022年为29.4亿美元。预计该市场在预测期（2023-2030年）将以15.6%的年复合成长率扩张，到2030年将达到108.4亿美元。

全球CRISPR技术市场是生物技术领域中一个新兴且前景看好的领域。 CRISPR 是 Clustered Regularly Interspaced Short Palindromic Repeats 的缩写，是一项突破性的基因编辑技术，可以对生物体的 DNA 进行精确修改。这项技术因其在解决遗传疾病、推进治疗方法的开发和改变农业实践方面的潜力而受到广泛关注。 CRISPR技术市场经历了显着成长，预计在可预见的未来将继续扩大。推动这一增长的因素包括个人化医疗需求的增加、基因治疗的进步以及遗传疾病盛行率的上升。此外，CRISPR 技术在药物研发、市场开拓和诊断工具创建中的采用进一步推动了市场扩张。此外，工业生物技术部门利用 CRISPR 技术进行生物工程和生物製造。利用 CRISPR，研究人员可以开发新型酵素、生物燃料和特殊化学品，为传统製造流程提供永续的替代方案。总而言之，全球市场是一个快速发展、前景看好的领域，有潜力彻底改变各个产业。医疗保健、农业和工业生物技术的应用有望改善人类健康、增加粮食产量和推动永续製造。随着研究和开发的进展，解决伦理和法规问题对于确保未来负责任和有益地使用 CRISPR 技术至关重要。

世界各国政府正大幅增加对CRISPR技术的融资和投资。因此，该行业为研究和开发提供了有利的环境，从而实现突破性发现和开发市场。

本报告考察了全球 CRISPR 技术市场，并提供了市场概述、最终用户趋势、应用、地区以及参与市场的公司概况。

主要企业简介
- Editas Medicine, Inc.
- CRISPR Therapeutics
- Intellia Therapeutics
- Caribou Biosciences, Inc.
- Cellectis
- Precision Biosciences
- Sangamo Therapeutics
- Lonza Group Ltd.
- Merck KGaA
- Horizon Discovery Group plc
- Thermo Fisher Scientific
- Integrated DNA Technologies, Inc.
- GenScript Biotech Corporation
- Synthego Corporation
- New England Biolabs
- OriGene Technologies, Inc.
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Addgene
- Eurofins Scientific

简介目录

Product Code: SQMIG35H2108

Global CRISPR Technology Market size was valued at USD 2.54 billion in 2021 and is poised to grow from USD 2.94 billion in 2022 to USD 10.84 billion by 2030, growing at a CAGR of 15.6% during the forecast period (2023-2030).

The global CRISPR technology market is an emerging and promising sector within the field of biotechnology. CRISPR, an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is a groundbreaking gene-editing technology that allows precise modifications to be made to the DNA of living organisms. This technology has garnered significant attention due to its potential to address genetic disorders, drive advancements in therapy development, and revolutionize agricultural practices. The CRISPR technology market has witnessed substantial growth and is expected to continue expanding in the foreseeable future. Factors driving this growth include the increasing demand for personalized medicine, advancements in gene therapy, and the rising prevalence of genetic diseases. Additionally, the adoption of CRISPR technology in drug discovery, development, and the creation of diagnostic tools has further fueled market expansion. Furthermore, the industrial biotechnology sector is leveraging CRISPR technology for bioengineering and bio-manufacturing purposes. By employing CRISPR, researchers can develop novel enzymes, biofuels, and specialty chemicals, providing sustainable alternatives to traditional manufacturing processes. In conclusion, the global market is a rapidly evolving and promising sector with the potential to revolutionize various industries. Its applications in healthcare, agriculture, and industrial biotechnology offer the prospect of improving human health, enhancing food production, and advancing sustainable manufacturing. As research and development continue, addressing ethical and regulatory considerations is crucial to ensure responsible and beneficial use of CRISPR technology in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the global CRISPR Technology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segmental Analysis

Global CRISPR Technology Market is segmented by end-user, application, and region. Based on end-user, the market can be segmented into pharmaceutical and biotechnology companies and academic and research institutes. Based on application, the market is segmented into drug discovery and development and agriculture. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global CRISPR Technology Market Dynamics

Drivers of the Global CRISPR Technology Market

Growing investments and funding from governments

Governments from all around the world have significantly increased their financing and investment in CRISPR technology. As a result, the field now offers a favourable environment for research and development, enabling ground-breaking discoveries and advancing the market.

Restraints in the Global CRISPR Technology Market

Technical challenges

The field of gene editing is severely constrained by technical difficulties related to CRISPR technology. Despite the enormous potential of CRISPR, numerous challenges prevent its widespread application. These difficulties result from the complexity of accurate genome editing, off-target consequences, and effective delivery. For CRISPR technology to reach its full potential and experience its transformative effects across a variety of industries, it is imperative that these technological obstacles be removed.

Market Trends of Global CRISPR Technology Key

One key market trend in the CRISPR technology market is the increasing adoption of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are recognizing the potential of CRISPR technology to accelerate the drug discovery process, improve target identification and validation, and enhance preclinical and clinical studies. CRISPR-based screening platforms allow researchers to identify and validate potential drug targets more efficiently, leading to the development of more effective therapies. Additionally, CRISPR enables the creation of disease models and organoids for studying disease mechanisms and evaluating drug candidates. Overall, the key market trends in the CRISPR technology market include the adoption of CRISPR in drug discovery, its applications in agriculture and food production, the development of CRISPR-based diagnostics, and the increasing emphasis on ethical and regulatory considerations. These trends highlight the expanding potential and impact of CRISPR technology across various industries.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global CRISPR Technology Market by End-User
- Market Overview
- Pharmaceutical and biotechnology companies and academic and research institutes
Global CRISPR Technology Market by Application
- Market Overview
- Drug discovery and development and agriculture
Global CRISPR Technology Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Editas Medicine, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CRISPR Therapeutics (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Intellia Therapeutics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Caribou Biosciences, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cellectis (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Precision Biosciences (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sangamo Therapeutics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lonza Group Ltd. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Horizon Discovery Group plc (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Thermo Fisher Scientific (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Integrated DNA Technologies, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GenScript Biotech Corporation (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Synthego Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- New England Biolabs (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- OriGene Technologies, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Agilent Technologies, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Takara Bio Inc. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Addgene (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eurofins Scientific (Luxembourg)
Company Overview
Business Segment Overview
Financial Updates
Key Developments